Ameriprise
MJN

Ameriprise’s Mead Johnson Nutrition Company MJN Stock Holding History

Ameriprise’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-210,486
Closed -$18.8M – 3853
2017
Q1 		$18.8M Sell
210,486
-20,224
-9% -$1.66M 0.01% 1064
2016
Q4 		$16.3M Sell
230,710
-516,224
-69% -$38.5M 0.01% 1128
2016
Q3 		$59M Sell
746,934
-113,857
-13% -$9.71M 0.03% 449
2016
Q2 		$78.1M Buy
860,791
+424,290
+97% +$35.9M 0.05% 377
2016
Q1 		$37.1M Buy
436,501
+7,984
+2% +$594K 0.02% 591
2015
Q4 		$33.8M Sell
428,517
-210,866
-33% -$16.6M 0.02% 629
2015
Q3 		$45M Sell
639,383
-1,855,222
-74% -$153M 0.03% 522
2015
Q2 		$225M Sell
2,494,605
-1,057,056
-30% -$102M 0.13% 162
2015
Q1 		$357M Sell
3,551,661
-173,768
-5% -$17.5M 0.2% 109
2014
Q4 		$375M Sell
3,725,429
-1,180,899
-24% -$118M 0.22% 117
2014
Q3 		$472M Sell
4,906,328
-311,381
-6% -$29.5M 0.28% 77
2014
Q2 		$486M Buy
5,217,709
+867,504
+20% +$75.9M 0.29% 83
2014
Q1 		$362M Buy
4,350,205
+12,326
+0.3% +$999K 0.22% 114
2013
Q4 		$363M Sell
4,337,879
-404,554
-9% -$32.9M 0.22% 111
2013
Q3 		$352M Sell
4,742,433
-454,399
-9% -$34.1M 0.23% 98
2013
Q2 		$412M Buy
+5,196,832
New +$417M 0.29% 68

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Ameriprise's MJN Position: Q2 2017 in Review

Ameriprise sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 210,486 shares — an estimated $18.8M sold.

Ameriprise first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $486M in Q2 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Ameriprise reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Ameriprise sold 210,486 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $18.8M.
  • Ameriprise first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Ameriprise's Mead Johnson Nutrition Company position peaked at $486M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Ameriprise's 13F filing for Q2 2017, filed 10 Aug 2017.